AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 179 filers reported holding AERIE PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 0.75 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $1,350,000 | -44.1% | 100,000 | 0.0% | 0.27% | -8.1% |
| Q4 2019 | $2,417,000 | +54.7% | 100,000 | +89.1% | 0.30% | +38.8% |
| Q2 2019 | $1,562,000 | -46.7% | 52,873 | -14.4% | 0.21% | -50.6% |
| Q1 2019 | $2,932,000 | -56.6% | 61,735 | -67.0% | 0.43% | -18.3% |
| Q4 2018 | $6,756,000 | +62.9% | 187,156 | +177.7% | 0.53% | +8.8% |
| Q3 2018 | $4,148,000 | -8.9% | 67,394 | 0.0% | 0.49% | -14.6% |
| Q2 2018 | $4,552,000 | +8.9% | 67,394 | -12.6% | 0.57% | +3.6% |
| Q1 2018 | $4,181,000 | -9.2% | 77,072 | 0.0% | 0.55% | -9.4% |
| Q4 2017 | $4,605,000 | +17.9% | 77,072 | -4.1% | 0.61% | +14.3% |
| Q3 2017 | $3,906,000 | -3.1% | 80,366 | +4.8% | 0.53% | -8.0% |
| Q2 2017 | $4,031,000 | +1.4% | 76,707 | -12.5% | 0.58% | -7.4% |
| Q1 2017 | $3,975,000 | -9.7% | 87,662 | -24.6% | 0.62% | -14.1% |
| Q4 2016 | $4,403,000 | -24.3% | 116,315 | -24.5% | 0.72% | -22.6% |
| Q3 2016 | $5,816,000 | +206.8% | 154,105 | +43.1% | 0.94% | +196.5% |
| Q2 2016 | $1,896,000 | +727.9% | 107,700 | +472.3% | 0.32% | +710.3% |
| Q1 2016 | $229,000 | -32.0% | 18,820 | +36.2% | 0.04% | -26.4% |
| Q4 2015 | $337,000 | -56.6% | 13,820 | -68.5% | 0.05% | -58.6% |
| Q3 2015 | $777,000 | -91.3% | 43,820 | -84.6% | 0.13% | -89.7% |
| Q1 2015 | $8,892,000 | +44.8% | 283,725 | +34.9% | 1.24% | +39.1% |
| Q4 2014 | $6,141,000 | +39.6% | 210,396 | -1.0% | 0.89% | +32.8% |
| Q3 2014 | $4,399,000 | +49.2% | 212,627 | +78.6% | 0.67% | +55.1% |
| Q2 2014 | $2,949,000 | +20.7% | 119,045 | +3.2% | 0.43% | +21.9% |
| Q1 2014 | $2,444,000 | +324.3% | 115,341 | +259.7% | 0.36% | +339.5% |
| Q4 2013 | $576,000 | – | 32,064 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 246,563 | $2,244,000 | 1.36% |
| LEVIN CAPITAL STRATEGIES, L.P. | 1,435,876 | $13,066,000 | 1.26% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 4,695,020 | $42,725,000 | 0.96% |
| DCF Advisers, LLC | 189,565 | $1,725,000 | 0.76% |
| DAFNA Capital Management LLC | 289,040 | $2,630,000 | 0.68% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,678,609 | $15,275,000 | 0.61% |
| Rhenman & Partners Asset Management AB | 589,200 | $5,362,000 | 0.53% |
| PFM Health Sciences, LP | 1,088,566 | $9,906,000 | 0.37% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 309,778 | $2,819,000 | 0.36% |
| Granahan Investment Management | 1,588,944 | $14,459,000 | 0.36% |